Drugs / oxalipaltin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06748508 | Dec 2024 → Jul 2027 expected | gastric cancer | Fudan University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oxalipaltin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06748508 ↗ |
| Route | Intravenous | “oxaliplatin 130mg/m2 ivgtt d1” NCT06748508 ↗ |